Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib price?In what ways has the generic option influenced ruxolitinib's market share?Defense strategy against generic in niche market?How many years does kadcyla's market exclusivity last?How might diet alleviate lipitor's liver impact?
See the DrugPatentWatch profile for Zavegepant
Zavegepant (Zavzpret) received FDA approval on March 12, 2023 [1].
The provided information only supports the FDA approval date (March 12, 2023) [1]. If you want, tell me which country/region you mean and I can help narrow it down to the local regulatory decision date.
This refers to the drug’s regulatory authorization (FDA approval) for zavegepant under its marketed name, Zavzpret [1].
1
Other Questions About Zavegepant :